Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 278

1.

Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin.

Rittié L, Kansra S, Stoll SW, Li Y, Gudjonsson JE, Shao Y, Michael LE, Fisher GJ, Johnson TM, Elder JT.

Am J Pathol. 2007 Jun;170(6):2089-99.

2.

Regulation of parathyroid hormone-related protein gene expression by epidermal growth factor-family ligands in primary human keratinocytes.

Cho YM, Lewis DA, Koltz PF, Richard V, Gocken TA, Rosol TJ, Konger RL, Spandau DF, Foley J.

J Endocrinol. 2004 Apr;181(1):179-90.

4.

Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.

Tanaka Y, Miyamoto S, Suzuki SO, Oki E, Yagi H, Sonoda K, Yamazaki A, Mizushima H, Maehara Y, Mekada E, Nakano H.

Clin Cancer Res. 2005 Jul 1;11(13):4783-92.

5.

Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostate.

Adam RM, Borer JG, Williams J, Eastham JA, Loughlin KR, Freeman MR.

Endocrinology. 1999 Dec;140(12):5866-75.

PMID:
10579352
6.

Upregulation of epidermal growth factor receptor 4 in oral leukoplakia.

Kobayashi H, Kumagai K, Gotoh A, Eguchi T, Yamada H, Hamada Y, Suzuki S, Suzuki R.

Int J Oral Sci. 2013 Mar;5(1):14-20. doi: 10.1038/ijos.2013.10. Epub 2013 Mar 15.

8.

Expression and regulation of c-ERBB ligands in human head and neck squamous carcinoma cells.

O-Charoenrat P, Rhys-Evans P, Eccles S.

Int J Cancer. 2000 Dec 1;88(5):759-65.

9.

Expression of epiregulin, a novel epidermal growth factor ligand associated with prognosis in human oral squamous cell carcinomas.

Shigeishi H, Higashikawa K, Hiraoka M, Fujimoto S, Mitani Y, Ohta K, Takechi M, Kamata N.

Oncol Rep. 2008 Jun;19(6):1557-64.

PMID:
18497965
10.

Differential effects of EGFR ligands on endocytic sorting of the receptor.

Roepstorff K, Grandal MV, Henriksen L, Knudsen SL, Lerdrup M, Grøvdal L, Willumsen BM, van Deurs B.

Traffic. 2009 Aug;10(8):1115-27. doi: 10.1111/j.1600-0854.2009.00943.x. Epub 2009 May 19.

11.

Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.

Shin HS, Lee HJ, Nishida M, Lee MS, Tamura R, Yamashita S, Matsuzawa Y, Lee IK, Koh GY.

Circ Res. 2003 Aug 22;93(4):302-10. Epub 2003 Jul 17.

12.

Luteinizing hormone signaling in preovulatory follicles involves early activation of the epidermal growth factor receptor pathway.

Panigone S, Hsieh M, Fu M, Persani L, Conti M.

Mol Endocrinol. 2008 Apr;22(4):924-36. doi: 10.1210/me.2007-0246. Epub 2008 Jan 10.

13.

Expression of the epidermal growth factor system in human middle ear cholesteatoma.

Thorup MB, Munk M, Poulsen SS, Gaihede M, Nexo E, Sorensen BS, Ovesen T.

Acta Otolaryngol. 2014 Feb;134(2):124-34. doi: 10.3109/00016489.2013.847282. Epub 2013 Nov 21.

PMID:
24256036
14.

Evolution of the predictive markers amphiregulin and epiregulin mRNAs during long-term cetuximab treatment of KRAS wild-type tumor cells.

Oliveras-Ferraros C, Massaguer Vall-Llovera A, Carrion Salip D, Vazquez-Martin A, Cufí S, Queralt B, Martin-Castillo B, Brunet J, de Llorens R, Menendez JA.

Invest New Drugs. 2012 Apr;30(2):846-52. doi: 10.1007/s10637-010-9612-2. Epub 2010 Dec 16.

PMID:
21161326
15.

Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis.

Oshima H, Popivanova BK, Oguma K, Kong D, Ishikawa TO, Oshima M.

Cancer Sci. 2011 Apr;102(4):713-9. doi: 10.1111/j.1349-7006.2011.01847.x. Epub 2011 Feb 2.

16.

EGF-like growth factors induce COX-2-derived PGE2 production through ERK1/2 in human granulosa cells.

Fang L, Cheng JC, Chang HM, Sun YP, Leung PC.

J Clin Endocrinol Metab. 2013 Dec;98(12):4932-41. doi: 10.1210/jc.2013-2662. Epub 2013 Oct 3.

PMID:
24092824
17.

Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.

Tilli CM, Ramaekers FC, Broers JL, Hutchison CJ, Neumann HA.

Br J Dermatol. 2003 Jan;148(1):102-9.

PMID:
12534602
18.

Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.

Stoebner PE, Le Gallic L, Berthe ML, Boulle N, Lallemant B, Marque M, Gaspard C, Delfour C, Lavabre-Bertrand T, Martinez J, Meunier L.

Exp Dermatol. 2008 Nov;17(11):908-15. doi: 10.1111/j.1600-0625.2008.00718.x. Epub 2008 Mar 12.

PMID:
18341568
19.

Supplemental Content

Support Center